Influence of plasma T790M mutation on clinical decision after 1st generation EGFR-TKI resistance in a Real-world study

被引：0
|
作者：
Zhang, S. [1 ]
Zhu, L. [2 ]
Xia, B. [2 ]
Chen, X. [3 ]
Ma, S. [2 ]
机构：
[1] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Hangzhou Translat Med Res Ctr, Hangzhou, Zhejiang, Peoples R China
[2] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Radiat Oncol, Hangzhou, Zhejiang, Peoples R China
[3] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1332P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.
    Kim, E. Y.
    Kim, A.
    Chang, Y. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S802 - S802
  • [12] Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI Resistance
    Zhang, Yidan
    Xu, Yingqi
    Xu, Jianlin
    Zhong, Hua
    Xia, Jinjing
    Zhong, Runbo
    CANCER SCIENCE, 2024,
  • [13] Detection of T790M mutation in EGFR gene, an EGFR-TKI resistant mutation, in tumor samples unexposed to EGFR TKIs
    Koba, Hayato
    Kimura, Hideharu
    Nishikawa, Shingo
    Yoneda, Taro
    Sone, Takashi
    Kasahara, Kazuo
    CANCER RESEARCH, 2016, 76
  • [14] Association between EGFR gene mutant protein expression and T790M mutation after first-generation EGFR-TKI treatment resistance: a retrospective, single-arm clinical study
    Zhang, Yiruo
    Huang, Xin
    Niu, Ruiqi
    Li, Chenghui
    Pang, Jingdan
    Liu, Pingping
    Adachi, Hiroyuki
    Kawase, Akikazu
    Yamaguchi, Fumihiro
    Du, Yingying
    ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [15] Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
    Zheng, Di
    Ye, Xin
    Zhang, Meizhuo
    Sun, Yun
    Wang, Jiying
    Ni, Jian
    Zhang, Haiping
    Zhang, Ling
    Luo, Jie
    Zhang, Jie
    Tang, Liang
    Su, Bo
    Chen, Gang
    Zhu, Guanshan
    Gu, Yi
    Xu, Jianfang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [16] Relationship between T790M Mutation in Advanced Lung Adenocarcinoma and Clinical Characteristics after EGFR-TKI Resistance and its Effect on mPFS and mOS
    Zhai, Zhanqiang
    Ye, Ye
    Li, Xiaofeng
    Zhu, Youcai
    Lan, Gang
    Chen, Huafei
    Huang, Lichao
    Gao, Yong
    Chen, Puen
    Min, Yonghua
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (12): : 6911 - 6917
  • [17] Characterization of T790M According to Primary EGFR Mutation in Post EGFR-TKI Progression NSCLC in Brazil
    Ferreira, C.
    Zalis, M.
    Custodio, M.
    Montenegro, G.
    Zukin, M.
    Mathias, C.
    Haddad, C.
    Mascarenhas, E.
    Araujo, L.
    Montella, T.
    Da Silva, B.
    Bustamante, C.
    Muras, A.
    Reis, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S158 - S158
  • [18] Effect of rebiopsy methods and clinical features on T790M mutation after first-line EGFR-TKI treatment failure
    Zhou, Jia
    Li, Yishi
    Zhang, Yangli
    Dai, Haiyun
    Guo, Shuliang
    FUTURE ONCOLOGY, 2021, 17 (19) : 2475 - 2488
  • [19] Association between advanced NSCLC T790M EGFR-TKI secondary resistance and prognosis A observational study
    Wang, Yuli
    Wei, Yuan
    Ma, Xiaoping
    Ma, Xinyu
    Gong, Ping
    MEDICINE, 2018, 97 (28)
  • [20] Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC
    Yang, Shuo
    Mao, Shiqi
    Li, Xuefei
    Zhao, Chao
    Liu, Qian
    Yu, Xiaofei
    Wang, Yan
    Liu, Yiwei
    Pan, Yingying
    Wang, Chunyan
    Gao, Guanghui
    Li, Wei
    Xiong, Anwen
    Chen, Bin
    Sun, Hui
    He, Yayi
    Wu, Fengying
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2020, 139 : 133 - 139
12345